Kevin Ban joins Walgreens from athenahealth, where he was chief medical officer, and brings more than 20 years of clinical experience, medical systems innovation leadership and performance improvement efforts to the role.
Alembic's generic Temovate provides a short-term topical treatment of inflammatory and pruritic manifestations of moderate to severe corticosteroid-responsive dermatoses of the scalp.
Twenty-nine of the 48 novel drug approvals of 2019, or 60%, were designated in one or more expedited categories of Fast Track, Breakthrough, Priority Review, and/or Accelerated Approval.
Panelists at the DSN Industry Issues Summit in December pointed to complex hurdles for pharmacists and patients in driving adherence and improved outcomes.
Enhertu is indicated for the treatment of patients with unresectable or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens.